Key Documents
Alexander Colevas
Academic Appointments
- Associate Professor - Med Center Line, Medicine - Oncology
- Associate Professor - Med Center Line (By courtesy), Otolaryngology (Head and Neck Surgery)
- Member, Cancer Center
Contact Information
-
Clinical Offices
Oncology 875 Blake Wilbur Dr MC 5826 Stanford, CA 94305 Tel Work (650) 724-9707 Fax (650) 498-5800
Professional Snapshot
Clinical Focus
- Cancer > Head and Neck Cancer
- Medical Oncology
- Oncology (Cancer)
- developmental therapeutics
- investigational new drugs
Professional Education
| Board Certification: | Medical Oncology, American Board of Internal Medicine (2005) |
| Board Certification: | Internal Medicine, American Board of Internal Medicine (2002) |
| Fellowship: | Dana-Farber Cancer Institute, MA (1995) |
| Residency: | Johns Hopkins School of Medicine, MD (1992) |
| Internship: | Johns Hopkins School of Medicine, MD (1990) |
Graduate & Fellowship Program Affiliations
Scientific Focus
Research Interests
Multi- modality treatment of Head and Neck Cancer
Phase 1 clinical trials
Clinical Trials
- BIBW 2992 in Head&Neck Cancer Recruiting
- Biopsy of human tumors for cancer stem cell characterization: a feasibility study Recruiting
- Docetaxel, Cisplatin, Fluorouracil, Bevacizumab, and Radiation Therapy in Treating Patients With Advanced Nasopharyngeal Carcinoma Recruiting
- Phase 3 Efficacy Study of XL184 in Adults With Medullary Thyroid Cancer Recruiting
- A Phase 1 Dose Escalation Study of OMP-21M18 in Subjects With Solid Tumors Recruiting
Publications
- Long-term outcomes and toxicity of concurrent paclitaxel and radiotherapy for locally advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2009; (4): 1040-6
- Molecular and Clinical Responses in a Pilot Study of Gefitinib with Paclitaxel and Radiation in Locally Advanced Head-and-Neck Cancer. Int J Radiat Oncol Biol Phys. 2009
- Phase II study of ispinesib in recurrent or metastatic squamous cell carcinoma of the head and neck. Invest New Drugs. 2008; (3): 257-64
- Head and neck cancers. J Natl Compr Canc Netw. 2008; (7): 646-95
- A multicentre phase II clinical experience with the novel aza-epothilone Ixabepilone (BMS247550) in patients with relapsed or refractory indolent non-Hodgkin lymphoma and mantle cell lymphoma. Br J Haematol. 2008; (2): 201-9
Help